Key result
Supervised exercise lowers fibrinogen ~83 mg/dL and halves pain scores in obese diabetic adults.
Answers are grounded in this paper and cite their sources.
[Purpose] To analyze the impact of a combined physiotherapeutic exercise program for type 2 diabetic adults with obesity and poor health-related quality of life strongly linked to pain. [Subjects] Twenty-five patients, mean age 58 ± 7.8, referred from an endocrinology service, were included. [Methods] They performed 12 weeks of supervised physiotherapeutic exercise for 180-minutes/week. Anamnesis, anthropometric, clinical and laboratory data were recorded before and after the intervention. [Results] Among the participants, 84% had musculoskeletal dysfunction associated with pain, 8% had neuropathic complications and 4% vascular complications. Fibrinogen (mg/dl) (T1: 404.7 ± 77.3; T2: 321.7 ± 99.4), hip circumference (cm) (T1: 118.5 ± 21.7; T2: 113.7 ± 14), skinfold sum (mm) (T1: 208.5 ± 90.2; T2: 202.5 ± 86.9) and visual analog scale (T1: 6.1 ± 2.5; T2: 3.1 ± 2.2) decreased significantly after treatment. From quality of life charts, only the outcomes related to social activities did not improve significantly. There were significant improvements in physical condition data, with the exceptions of upper limb strength resistance and balance related measurements. [Conclusion] The intervention substantially improved cardiovascular risk, quality of life and physical condition and composition of middle-aged type 2 diabetic adults with obesity and neuromusculoskeletal disorders.
No takes yet. Share an insight, caveat, or question.
Lucha-López et al. (2012) studied Type 2 diabetes mellitus and obesity (n=25). Supervised physiotherapeutic exercise program vs. Baseline (pre-intervention) was evaluated on Anthropometric, clinical, laboratory, quality of life, and physical condition parameters (including fibrinogen, hip circumference, skinfold sum, and visual analog scale for pain). Supervised physiotherapeutic exercise for 12 weeks significantly reduced fibrinogen (404.7 to 321.7 mg/dl) and pain VAS scores (6.1 to 3.1) in obese adults with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: